Biolinerx Ltd.

Israël


 
Quantité totale PI 67
Rang # Quantité totale PI 20 032
Note d'activité PI 2,6/5.0    60
Rang # Activité PI 11 994
Symbole boursier
ISIN IL0011015182
Capitalisation 92.1M  (ILA)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

20 4
7 2
30 4
0
 
Dernier brevet 2024 - Methods of hematopoietic precurs...
Premier brevet 2006 - Novel salts of conjugated psycho...
Dernière marque 2023 - BIOLINERX
Première marque 2022 - APHEXDA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Methods of hematopoietic precursor cells mobilization. A method of mobilizing hematopoietic precu...
2023 Invention Composition of bl-8040. A composition comprising BL-8040 (SEQ ID NO: 1) is disclosed herein, whi...
Invention Treatment of sickle cell disease. A method of mobilizing CD34+ cells in a subject suffering from ...
P/S Pharmaceutical product development services, namely, pharmaceutical product development through t...
P/S Pharmaceutical development services, namely pharmaceutical development through the discovery of ...
2022 P/S Medicine for mobilization of stem cells.
P/S Medicine for mobilization of stem cells
P/S Medicine for mobilization of stem cells.
2021 Invention Process for manufacturing peptide. (vii) substitution of the resin is at least 0.3 milliequivalen...
Invention Composition of bl-8040. A composition comprising BL-8040 (SEQ ID NO: 1) is disclosed herein, whic...
Invention Process for manufacturing peptide. A large-scale process is described herein for preparing a cycl...
Invention Cxcr4 inhibitor for the treatment of acute respiratory distress syndrome and viral infections. A...
Invention Cxcr4 inhibitor for the treatment of acute respiratory distress syndrome and viral infections. A ...
2020 Invention Compositions, articles of manufacture and methods for treating cancer. A method of treating canc...
Invention Combination therapy for the treatment of cancer. A method of treating a solid tumor in a subject ...
Invention Compositions and methods for treating cancer. Use of a CXCR4 antagonistic peptide and an immune-c...
Invention Compositions and methods for treating cancer. Use of a CXCR4 antagonistic peptide and an immune-...
2019 Invention Specific combination therapy for treatment of pancreatic cancer. A method of treating metastatic...
Invention Specific combination therapy for treatment of pancreatic cancer. A method of treating metastatic ...
Invention Combination therapy for treatment of pancreatic cancer. A method of treating metastatic pancreati...
Invention Treatment of metastatic pancreatic adenocarcinoma. A method of treating metastatic pancreatic ade...
Invention Methods of selecting treatment for cxcr4-associated cancer. A method of selecting a treatment re...
Invention Methods of selecting treatment for cxcr4-associated cancer. A method of selecting a treatment reg...
Invention Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors. A method of trea...
Invention Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors. A method of treat...
2018 Invention Methods of treating acute myeloid leukemia with a flt3 mutation. There is provided a method of t...
Invention Methods of treating diseases associated with vascular smooth muscle cell proliferation. A method...
Invention Methods of treating diseases associated with vascular smooth muscle cell proliferation. A method ...
Invention Methods of treating myeloid leukemia. There is provided a method of treating a myeloid leukemia....
2016 Invention Cxcr4 binding agents for treatment of diseases. A method of treating cancer in a subject is disc...
Invention Methods of obtaining mononuclear blood cells and uses thereof. Methods of obtaining mononuclear ...